Finance entity
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Controlled Substances Act, the most common co-covered peer. We currently track 1 Finance story that mention Catalent, all published on July 30, 2026.
Last mentioned: Jul 30, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Controlled Substances Act, the most common co-covered peer. We currently track 1 Finance story that mention Catalent, all published on July 30, 2026. Each carries 4 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Catalent. Shared-story counts are live from our verified record — not editorial picks.
Investors face renewed uncertainty as a federal court considers whether the Attorney General acted improperly in moving state medical marijuana to Schedule III. An adverse ruling could unwind tax and banking benefits that have underpinned bullish cannabis investment theses, potentially erasing billions in market capitalization.
Catalent is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
